Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab

NCT01922037 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01922037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01922037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab
Lead sponsor
Hoffmann-La Roche
Phase
Phase 4
Overall status
Completed
Start date
June 19, 2013
Completion date
March 31, 2016
Enrollment
806 (actual)
Sites
145

Conditions

As the registry lists them; a condition with its own page is linked.

asthma